JP2018520170A5 - - Google Patents

Download PDF

Info

Publication number
JP2018520170A5
JP2018520170A5 JP2018500737A JP2018500737A JP2018520170A5 JP 2018520170 A5 JP2018520170 A5 JP 2018520170A5 JP 2018500737 A JP2018500737 A JP 2018500737A JP 2018500737 A JP2018500737 A JP 2018500737A JP 2018520170 A5 JP2018520170 A5 JP 2018520170A5
Authority
JP
Japan
Prior art keywords
pyrrolo
pyridin
ethanone
methyl
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018500737A
Other languages
English (en)
Japanese (ja)
Other versions
JP6964576B2 (ja
JP2018520170A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/041339 external-priority patent/WO2017007938A1/en
Publication of JP2018520170A publication Critical patent/JP2018520170A/ja
Publication of JP2018520170A5 publication Critical patent/JP2018520170A5/ja
Priority to JP2021138906A priority Critical patent/JP7369743B2/ja
Application granted granted Critical
Publication of JP6964576B2 publication Critical patent/JP6964576B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018500737A 2015-07-09 2016-07-07 置換4−アザインドール及びglun2b受容体調節因子としてのそれらの使用 Active JP6964576B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021138906A JP7369743B2 (ja) 2015-07-09 2021-08-27 置換4-アザインドール及びglun2b受容体調節因子としてのそれらの使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562190416P 2015-07-09 2015-07-09
US62/190,416 2015-07-09
PCT/US2016/041339 WO2017007938A1 (en) 2015-07-09 2016-07-07 Substituted 4-azaindoles and their use as glun2b receptor modulators

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021138906A Division JP7369743B2 (ja) 2015-07-09 2021-08-27 置換4-アザインドール及びglun2b受容体調節因子としてのそれらの使用

Publications (3)

Publication Number Publication Date
JP2018520170A JP2018520170A (ja) 2018-07-26
JP2018520170A5 true JP2018520170A5 (cg-RX-API-DMAC7.html) 2019-07-25
JP6964576B2 JP6964576B2 (ja) 2021-11-10

Family

ID=56497884

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018500737A Active JP6964576B2 (ja) 2015-07-09 2016-07-07 置換4−アザインドール及びglun2b受容体調節因子としてのそれらの使用
JP2021138906A Active JP7369743B2 (ja) 2015-07-09 2021-08-27 置換4-アザインドール及びglun2b受容体調節因子としてのそれらの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021138906A Active JP7369743B2 (ja) 2015-07-09 2021-08-27 置換4-アザインドール及びglun2b受容体調節因子としてのそれらの使用

Country Status (25)

Country Link
US (2) US9963447B2 (cg-RX-API-DMAC7.html)
EP (1) EP3319963B1 (cg-RX-API-DMAC7.html)
JP (2) JP6964576B2 (cg-RX-API-DMAC7.html)
KR (1) KR20180026760A (cg-RX-API-DMAC7.html)
CN (1) CN108026094B (cg-RX-API-DMAC7.html)
AU (1) AU2016291158B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018000468A2 (cg-RX-API-DMAC7.html)
CA (1) CA2991765C (cg-RX-API-DMAC7.html)
CY (1) CY1123007T1 (cg-RX-API-DMAC7.html)
DK (1) DK3319963T3 (cg-RX-API-DMAC7.html)
EA (1) EA033197B1 (cg-RX-API-DMAC7.html)
ES (1) ES2781867T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20200410T1 (cg-RX-API-DMAC7.html)
HU (1) HUE047460T2 (cg-RX-API-DMAC7.html)
IL (1) IL256758A (cg-RX-API-DMAC7.html)
LT (1) LT3319963T (cg-RX-API-DMAC7.html)
MA (1) MA42397B1 (cg-RX-API-DMAC7.html)
MD (1) MD3319963T2 (cg-RX-API-DMAC7.html)
MX (1) MX2018000352A (cg-RX-API-DMAC7.html)
PL (1) PL3319963T3 (cg-RX-API-DMAC7.html)
PT (1) PT3319963T (cg-RX-API-DMAC7.html)
SI (1) SI3319963T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202000134T1 (cg-RX-API-DMAC7.html)
WO (1) WO2017007938A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201800827B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3180329T (pt) 2014-08-15 2020-06-08 Janssen Pharmaceuticals Inc Triazóis como inibidores do recetor nr2b
USRE49517E1 (en) 2014-08-15 2023-05-02 Janssen Pharmaceuticals, Inc. Pyrazoles
HRP20200410T1 (hr) * 2015-07-09 2020-08-21 Janssen Pharmaceutica Nv Supstituirani 4-azaindoli i njihova upotreba kao modulatora glun2b receptora
CN109071488B (zh) 2016-02-10 2021-08-13 詹森药业有限公司 取代的1,2,3-三唑作为nr2b-选择性nmda调节剂
TW201819376A (zh) * 2016-10-06 2018-06-01 比利時商健生藥品公司 經取代之1H-咪唑並[4,5-b]吡啶-2(3H)-酮及其作為GLUN2B受體調節劑之用途
US11447503B2 (en) 2019-06-14 2022-09-20 Janssen Pharmaceutica Nv Pyridine carbamates and their use as GLUN2B receptor modulators
JP7346441B2 (ja) * 2018-04-04 2023-09-19 ヤンセン ファーマシューティカ エヌ.ベー. 置換ピリジン及びピリミジン並びにglun2b受容体調節物質としてのそれらの使用
TW202112774A (zh) * 2019-06-14 2021-04-01 比利時商健生藥品公司 經取代之吡唑并-吡啶醯胺及其作為glun2b受體調節劑之用途
JP2022536424A (ja) * 2019-06-14 2022-08-16 ヤンセン ファーマシューティカ エヌ.ベー. 置換ヘテロ芳香族ピラゾロピリジン及びglun2b受容体調節因子としてのそれらの使用
CA3142998A1 (en) 2019-06-14 2020-12-17 Janssen Pharmaceutica Nv Pyrazine carbamates and their use as glun2b receptor modulators
KR20220020917A (ko) * 2019-06-14 2022-02-21 얀센 파마슈티카 엔.브이. 치환된 피라졸로[4,3-b]피리딘 및 GLUN2B 수용체 조절제로서의 이들의 용도
MX2021015500A (es) 2019-06-14 2022-02-10 Janssen Pharmaceutica Nv Pirazolo-pirazinas sustituidas y su uso como moduladores del receptor glun2b.
PH12021552839A1 (en) 2019-06-14 2022-10-03 Janssen Pharmaceutica Nv Substituted pyrazolo-pyridine amides and their use as glun2b receptor modulators
CN114621125B (zh) * 2020-12-14 2024-07-09 中国科学技术大学 Nlrp3炎症小体抑制剂及其应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1490364B1 (en) * 2002-03-28 2007-09-26 Eisai R&D Management Co., Ltd. 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
TW200604183A (en) 2004-02-18 2006-02-01 Astrazeneca Ab Triazole compounds and their use as metabotropic glutamate receptor antagonists
US20060183758A1 (en) * 2005-02-17 2006-08-17 Cb Research And Development, Inc. Method for synthesis of AZA-annelated pyrroles, thiophenes, and furans
US7807704B2 (en) * 2006-03-30 2010-10-05 Chemocentryx, Inc. Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2
PE20090717A1 (es) * 2007-05-18 2009-07-18 Smithkline Beecham Corp Derivados de quinolina como inhibidores de la pi3 quinasa
KR20100017372A (ko) 2007-05-25 2010-02-16 애보트 게엠베하 운트 콤파니 카게 향대사성 글루타메이트 수용체 2(mglu2 수용체)의 포지티브 조절자로서의 헤테로사이클릭 화합물
WO2009005821A1 (en) 2007-07-03 2009-01-08 Edward Scott Carlson Support apparatus for climbing plants
EP2194045A4 (en) 2007-08-30 2011-09-21 Takeda Pharmaceutical Substituted pyrazole derivative
EP2215073A4 (en) 2007-10-31 2011-04-06 Merck Sharp & Dohme SLEEP MODULATION WITH NR2B RECEPTOR ANTAGONISTS
RU2499598C2 (ru) 2008-03-27 2013-11-27 Евотек Интернациональ Гмбх Способы лечения нарушений с применением селективного антагониста nr2b-подтипа nmda рецепторов
WO2010016490A1 (ja) 2008-08-05 2010-02-11 第一三共株式会社 イミダゾピリジン-2-オン誘導体
AU2009304293B2 (en) * 2008-10-16 2012-04-26 Addex Pharma S.A. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
EP3037421A3 (en) 2008-11-25 2016-11-30 University Of Rochester Mlk inhibitors and methods of use
TWI625121B (zh) * 2009-07-13 2018-06-01 基利科學股份有限公司 調節細胞凋亡信號之激酶的抑制劑
WO2011156245A2 (en) 2010-06-09 2011-12-15 Merck Sharp & Dohme Corp. Positive allosteric modulators of mglur2
WO2013130855A1 (en) 2012-03-02 2013-09-06 Takeda Pharmaceutical Company Limited Indazole derivatives
WO2014124651A1 (en) * 2013-02-15 2014-08-21 Københavns Universitet Pyrrolidine-2-carboxylic acid derivatives as iglur antagonists
EP2970200A1 (en) * 2013-03-13 2016-01-20 Abbvie Inc. Pyridine cdk9 kinase inhibitors
RU2680100C9 (ru) * 2013-03-15 2019-04-18 Плексксикон Инк. Гетероциклические соединения и их применения
CN103626767A (zh) * 2013-12-04 2014-03-12 上海药明康德新药开发有限公司 区域选择性的氮杂吲哚及其合成方法
PT3180329T (pt) 2014-08-15 2020-06-08 Janssen Pharmaceuticals Inc Triazóis como inibidores do recetor nr2b
USRE49517E1 (en) 2014-08-15 2023-05-02 Janssen Pharmaceuticals, Inc. Pyrazoles
HRP20200410T1 (hr) 2015-07-09 2020-08-21 Janssen Pharmaceutica Nv Supstituirani 4-azaindoli i njihova upotreba kao modulatora glun2b receptora
CN109071488B (zh) 2016-02-10 2021-08-13 詹森药业有限公司 取代的1,2,3-三唑作为nr2b-选择性nmda调节剂
TW201819376A (zh) 2016-10-06 2018-06-01 比利時商健生藥品公司 經取代之1H-咪唑並[4,5-b]吡啶-2(3H)-酮及其作為GLUN2B受體調節劑之用途

Similar Documents

Publication Publication Date Title
JP2018520170A5 (cg-RX-API-DMAC7.html)
HRP20200410T1 (hr) Supstituirani 4-azaindoli i njihova upotreba kao modulatora glun2b receptora
JP2019530695A5 (cg-RX-API-DMAC7.html)
JP7308220B2 (ja) オキサジンモノアシルグリセロールリパーゼ(magl)阻害剤
JP2016523911A5 (cg-RX-API-DMAC7.html)
JP2011500806A5 (cg-RX-API-DMAC7.html)
CN1902196B (zh) 噻唑衍生物
JP7609854B2 (ja) Magl阻害剤としての4,4a,5,7,8,8a-ヘキサピリド[4,3-b][1,4]オキサジン-3-オン化合物
JP2021533093A (ja) モノアシルグリセロールリパーゼ阻害剤としての新規複素環化合物
JP2016519156A5 (cg-RX-API-DMAC7.html)
JP2017502049A5 (cg-RX-API-DMAC7.html)
CN116531380A (zh) 用于治疗癌症的2-杂芳基-3-氧代-2,3-二氢哒嗪-4-甲酰胺
RU2021133444A (ru) Производные бензимидазола в качестве модуляторов ror-гамма
CN107624111A (zh) 作为激酶抑制剂的杂环酰胺
US9809573B2 (en) Substituted pyridine derivatives useful as GSK-3 inhibitors
JP2016523925A5 (cg-RX-API-DMAC7.html)
JP2019523233A5 (cg-RX-API-DMAC7.html)
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
CN104024250B (zh) 作为痕量胺相关受体(taar)的杂环衍生物
JP2017500364A5 (cg-RX-API-DMAC7.html)
JP2017528515A5 (cg-RX-API-DMAC7.html)
RU2016112952A (ru) Производные индола и индазола
JP2020503302A5 (cg-RX-API-DMAC7.html)
JP6255516B2 (ja) モルホリン−ピリジン誘導体
JPWO2020249791A5 (cg-RX-API-DMAC7.html)